Skip to content
The first shipment of Jynneos mpox vaccines arrived in the Democratic Republic of Congo (DRC) on Sept. 5, according to vaccine maker Bavarian Nordic. […]
First mpox vaccines arrive in DRC, epicenter of the international emergency Read More »
Neuroene Therapeutics is developing mitochondrial-protective small molecules for epilepsy, Parkinson’s, and mitochondrial diseases. The company’s CEO Sherine Chan, Ph.D., co-founded Neuroene with medicinal chemist
BIO Start-Up Stadium 2024: Meet Emerging Company winner Neuroene Therapeutics Read More »
Afreen Allam’s company, SiNON Nano Sciences, has been working tirelessly to overcome one of the most significant challenges in neurology: enabling drugs to cross
BIO Start-Up Stadium 2024: Meet Seed-Stage winner Afreen Allam and SiNON Nano Sciences Read More »
Pregnancy-related deaths in the U.S. have risen 140% over the past three decades, and cardiovascular disease is the leading cause, according to the American
Merck for Mothers addresses maternal cardiovascular risks Read More »
The U.S. Department of Agriculture began field safety trials of a vaccine to protect dairy cattle from avian flu, Agriculture Secretary Tom Vilsack said.
USDA testing vaccine to protect cows from bird flu Read More »
The U.S. Department of Agriculture (USDA) announced approval on Aug. 27 for growing wheat with the HB4 drought-tolerant trait, drawing praise from growers’ associations
USDA approves genetic trait that helps wheat handle drought Read More »
The announcement of “maximum fair prices” for the first 10 medicines targeted under the Inflation Reduction Act (IRA) has renewed questions and concerns about
The economics of the Inflation Reduction Act’s impact on innovation Read More »
Drug price controls in the Inflation Reduction Act (IRA) involve unconstitutional coercion and will destroy innovation in transformational treatments that save patients’ lives, the
BIO files amicus brief challenging IRA drug price controls Read More »
Food and Drug Administration (FDA) approval of updated COVID-19 mRNA vaccines came earlier than expected this year, giving us a new weapon against the
FDA greenlights updated COVID vaccines in time for summer surge Read More »
Australia’s Wagner Sustainable Fuel wants to equip its sustainable aviation fuel (SAF) refinery with a joint solution from LanzaTech and LanzaJet that turns municipal
LanzaTech and LanzaJet joint technology eyed for Australian SAF plant Read More »
